Hypomethylation of 111 Probes Predicts Poor Prognosis for Glioblastoma

Glioblastoma (GBM) is a complicated brain tumor with heterogeneous outcome. Identification of effective biomarkers is an urgent need for the treatment decision-making and precise evaluation of prognosis. Based on a relatively large dataset of genome-wide methylation (138 glioblastoma patients), a jo...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Qi, Zhao, Min, Yin, Chengliang, Feng, Shiyu, Hu, Jian, Zhang, Qiang, Ma, Xiaodong, Xue, Wanguo, Shi, Jinlong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823878/
https://www.ncbi.nlm.nih.gov/pubmed/31708732
http://dx.doi.org/10.3389/fnins.2019.01137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823878/
https://www.ncbi.nlm.nih.gov/pubmed/31708732
http://dx.doi.org/10.3389/fnins.2019.01137

Ejemplares similares